Alethea Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Small-Cap Growth ETF
VBK
|
+$1.66M |
| 2 |
Qualcomm
QCOM
|
+$198K |
| 3 |
Bank of America
BAC
|
+$262 |
| 4 |
Honeywell
HON
|
+$180 |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$517K |
| 2 |
CME Group
CME
|
+$505K |
| 3 |
GRMN
Garmin
GRMN
|
+$472K |
| 4 |
Gilead Sciences
GILD
|
+$455K |
| 5 |
Axsome Therapeutics
AXSM
|
+$451K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 86.4% |
| 2 | Industrials | 1.99% |
| 3 | Financials | 1.67% |
| 4 | Technology | 1.49% |
| 5 | Consumer Staples | 1.38% |
Similar funds
Alethea Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Alethea Capital Management held 53 positions worth $86.7M, up 6.5% from $81.4M the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Alethea Capital Management withdrew a net $6.95M in Q4 2023, closing 18 positions and reducing 9 holdings. Its most notable exit was AbbVie, an estimated $517K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 81% a quarter earlier, followed by Industrials and Financials.
Against the trend, Alethea Capital Management opened a new position in Vanguard Small-Cap Growth ETF worth $1.84M.
- Alethea Capital Management's largest Q4 2023 buy was Vanguard Small-Cap Growth ETF: 7,625 shares worth $1.84M.
- Alethea Capital Management added most to Bank of America in Q4 2023, an estimated $262 increase.
- Alethea Capital Management's biggest Q4 2023 reduction was Axsome Therapeutics, cutting an estimated $451K.
- Alethea Capital Management fully exited AbbVie in Q4 2023, selling an estimated $517K.
- Alethea Capital Management's ten largest holdings make up 92% of its $86.7M portfolio in Q4 2023.
- Alethea Capital Management opened 2 new positions and closed 18 in Q4 2023.
- Alethea Capital Management's portfolio value rose 6.5% quarter-over-quarter to $86.7M.
Based on Alethea Capital Management's 13F filing for Q4 2023, filed 15 Feb 2024.